Definitive Contract 140D6318C0006
Award Date
12/28/17
Potential Completion Date
11/27/22
Potential Value
$3M
Funding Federal Agency
Defense Advanced Research Projects Agency
Contracting Federal Agency
Interior Business Center
Awardee
Autonomous Therapeutics Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Brooklyn, NY 11205, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a $3,247,731 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Autonomous Therapeutics Inc., a small business biotechnology company. The contract is for the development of a first-in-human therapeutic interfering particle targeting a respiratory virus, under DARPA's research programs. Autonomous Therapeutics has also been awarded an Indefinite Delivery Vehicle (IDV) by DARPA, with a potential value of $4,579,822, to develop and deliver therapeutic...
This is a $225,000.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Technology Holding LLC, a small, for-profit limited liability company specializing in research and development services. The contract is part of DARPA's Small Business Innovation Research (SBIR) program and is for Phase I of an effort titled "AUTONOMOUS BIOMANUFACTORING AT REMOTE LOCATIONS". The contract has a total small business set-aside and supports the development of...
This is a $223,201 firm fixed price STTR Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Netrias, LLC, a small business AI company. The contract is for the development of "PATHENGINE: A PLATFORM TO AUTOMATE THE INTEGRATION OF DATA TO PREDICT PATHOGENIC POTENTIAL", which aligns with DARPA's mission of advancing transformative technologies for national security. The contract was awarded under DARPA's Small Business Technology Transfer (STTR)...
This is a $583,435.00 firm-fixed-price definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Senti Biosciences, Inc. for a Biological Technologies Office study on programmable therapeutic cell circuit platforms. The contract has a completion date of January 31, 2018 and does not have a set-aside designation. As DARPA is the Defense Department's advanced research agency, this contract is likely part of their efforts to develop novel biotechnology capabilities for...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Xilis Inc., a for-profit manufacturing organization. The contract is for the development of tissue-derived droplet micro-organospheres as models for high-throughput testing of pathogens, with a total potential value of $224,658.00. The contract has a firm fixed price pricing type and a completion date of August 31, 2021. The original solicitation was a Broad...
<p>This is a $149,500.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Nanomedical Diagnostics, Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES." The contract was awarded on October 24, 2016 with a final completion date of July 23, 2017.</p>
This is a $45,359,554.17 cost-plus-fixed-fee contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Sarepta Therapeutics, Inc. for the development of a new antiviral (antisense) product. The contract was awarded on November 29, 2006 with a completion date of February 28, 2011. The contract does not have a set-aside designation. Sarepta Therapeutics, Inc. is the prime contractor, and there is no information provided about major subcontractors. The DTRA is the funding...
This is a $995,075.00 cost-plus-fixed-fee Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA), a defense agency, to Deep Learning Analytics, LLC, a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the "DEEP BIOTHREAT ID" project, which appears to be related to biothreat identification. The contract has a period of performance that runs through February 14, 2020. No additional details about the...
This is a $1,492,018.00 Firm Fixed Price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Scribe Biosciences, Inc., a small business, under the SBIR Program Phase II. The contract is for the development of "NEW PLATFORM TECHNOLOGIES FOR VIRAL AND THERAPEUTIC EVOLUTION ASSAYS." This contract is set aside for small businesses. Scribe Biosciences has previously received awards from the National Institutes of Health, National Science Foundation, and...
This SBIR Phase II contract was awarded by the Defense Advanced Research Projects Agency (DARPA) to Quorum Innovations LLC, a small business located in Sarasota, Florida. The $1,249,032 Firm Fixed Price contract supports research into "Tough Self-Decontaminating Surfaces (TSDS) - Anti-Adhesive Protein for Human Respiratory Surface Defense Against Respiratory Viruses and Pathogens", with a focus on COVID-19. This research is part of DARPA's SBIR program to leverage small business...